Rediffmail Money rediffGURUS BusinessEmail

Cornerstone to sell Lupin drug in US

January 27, 2005 15:39 IST
Source:PTI
Lupin Pharmaceuticals Inc, the wholly owned subsidiary of Lupin, has entered into an alliance with Cornerstone BioPharma Inc.

Cornerstone will be Lupin's promotion partner in the US for its Suprax (cefixime) anti-infective.

"Cornerstone's sales force will co-promote Suprax with a focus on primary care physicians, who were not covered by us, with immediate effect," LPI managing director and president Vinita Gupta said on Thursday.

This partnership represents a significant expansion in the scope of physician coverage for Suprax in the $1.2 billion oral suspension anti-infective market, she added.

Source: PTI
© Copyright 2025 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.

WEB STORIES

8 Flippin Good Dosa Recipes

Have You Seen Any Of These 12 Things In India Lately?

Period Late? 8 Reasons Why

VIDEOS